Exact Sciences Corporation (EXAS) Position Lowered by SVA Plumb Wealth Management LLC

SVA Plumb Wealth Management LLC cut its position in shares of Exact Sciences Corporation (NASDAQ:EXAS) by 1.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 43,981 shares of the medical research company’s stock after selling 825 shares during the period. SVA Plumb Wealth Management LLC’s holdings in Exact Sciences Corporation were worth $1,556,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. State of Wisconsin Investment Board purchased a new position in shares of Exact Sciences Corporation during the 2nd quarter worth about $3,006,000. Neuberger Berman Group LLC purchased a new position in shares of Exact Sciences Corporation during the 1st quarter worth about $6,391,000. Nationwide Fund Advisors boosted its stake in shares of Exact Sciences Corporation by 52.1% during the 1st quarter. Nationwide Fund Advisors now owns 149,167 shares of the medical research company’s stock worth $3,523,000 after purchasing an additional 51,085 shares during the period. Victory Capital Management Inc. purchased a new position in shares of Exact Sciences Corporation during the 2nd quarter worth about $29,450,000. Finally, Eagle Asset Management Inc. boosted its stake in shares of Exact Sciences Corporation by 19.6% during the 2nd quarter. Eagle Asset Management Inc. now owns 1,857,185 shares of the medical research company’s stock worth $65,688,000 after purchasing an additional 304,598 shares during the period. 85.22% of the stock is owned by hedge funds and other institutional investors.

WARNING: “Exact Sciences Corporation (EXAS) Position Lowered by SVA Plumb Wealth Management LLC” was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this article on another domain, it was illegally copied and republished in violation of U.S. and international trademark and copyright law. The legal version of this article can be viewed at https://sportsperspectives.com/2017/09/12/exact-sciences-corporation-exas-position-lowered-by-sva-plumb-wealth-management-llc.html.

In related news, insider Graham Peter Lidgard sold 75,683 shares of Exact Sciences Corporation stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $40.81, for a total value of $3,088,623.23. Following the completion of the transaction, the insider now owns 308,377 shares in the company, valued at $12,584,865.37. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP D Scott Coward sold 1,987 shares of Exact Sciences Corporation stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $35.21, for a total transaction of $69,962.27. Following the completion of the transaction, the senior vice president now owns 57,603 shares of the company’s stock, valued at approximately $2,028,201.63. The disclosure for this sale can be found here. Insiders sold 129,291 shares of company stock valued at $5,288,181 in the last quarter. 4.00% of the stock is owned by insiders.

Several equities research analysts have issued reports on EXAS shares. Vetr cut shares of Exact Sciences Corporation from a “hold” rating to a “sell” rating and set a $34.70 price objective for the company. in a research report on Wednesday, July 12th. Leerink Swann set a $45.00 price objective on shares of Exact Sciences Corporation and gave the company a “buy” rating in a research report on Thursday, August 24th. Canaccord Genuity boosted their price objective on shares of Exact Sciences Corporation from $38.00 to $40.00 and gave the company a “buy” rating in a research report on Wednesday, May 31st. Zacks Investment Research raised shares of Exact Sciences Corporation from a “hold” rating to a “buy” rating and set a $39.00 price objective for the company in a research report on Tuesday, June 27th. Finally, Roth Capital boosted their price objective on shares of Exact Sciences Corporation from $40.00 to $46.00 and gave the company a “buy” rating in a research report on Wednesday, July 26th. Six equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. Exact Sciences Corporation presently has an average rating of “Buy” and an average price target of $40.98.

Exact Sciences Corporation (NASDAQ:EXAS) traded down 0.9173% on Tuesday, hitting $42.3975. 301,489 shares of the company traded hands. The firm’s market capitalization is $5.05 billion. The stock’s 50-day moving average is $39.49 and its 200 day moving average is $31.97. Exact Sciences Corporation has a 12 month low of $13.05 and a 12 month high of $43.29.

Exact Sciences Corporation (NASDAQ:EXAS) last issued its quarterly earnings results on Tuesday, July 25th. The medical research company reported ($0.27) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.10. Exact Sciences Corporation had a negative net margin of 83.08% and a negative return on equity of 36.36%. The company had revenue of $57.65 million during the quarter, compared to the consensus estimate of $47.73 million. Equities analysts forecast that Exact Sciences Corporation will post ($1.18) EPS for the current fiscal year.

Exact Sciences Corporation Company Profile

Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer.

Institutional Ownership by Quarter for Exact Sciences Corporation (NASDAQ:EXAS)

Receive News & Ratings for Exact Sciences Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exact Sciences Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply